000 | 01021 a2200301 4500 | ||
---|---|---|---|
005 | 20250517123356.0 | ||
264 | 0 | _c20170216 | |
008 | 201702s 0 0 eng d | ||
022 | _a2374-2445 | ||
024 | 7 |
_a10.1001/jamaoncol.2016.3634 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYu, Evan Y | |
245 | 0 | 0 |
_aAvoiding Undertreatment of Aggressive Prostate Cancer by Early Use of Chemotherapy. _h[electronic resource] |
260 |
_bJAMA oncology _cJan 2017 |
||
300 |
_a13-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aTaxoids _xtherapeutic use |
700 | 1 | _aLin, Daniel W | |
773 | 0 |
_tJAMA oncology _gvol. 3 _gno. 1 _gp. 13-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaoncol.2016.3634 _zAvailable from publisher's website |
999 |
_c26576701 _d26576701 |